Objective: This study is to evaluate the anti-obese effects of glucosamine (GLC) and
chitosan oligosaccharide (COS) on high-fat diet-induced obese rats. Methods: The rats were …

Obesity is a global disease that causes many metabolic disorders. However, effective agents
for the prevention or treatment of obesity remain limited. This study investigated the anti …

Background Hyperlipidemia (HLP) is the primary risk factor of cardiovascular disease (CVD).
Various factors, including genetics, physical inactivity, and daily nutritional habits, affect the …

Neoagarooligosaccharides (NAOs), mainly comprising neoagarotetraose and
neoagarohexaose, were prepared by hydrolyzing agar with β-agarase DagA from …

Excess body weight is a major risk factor for type 2 diabetes (T2D) and associated metabolic
complications, and weight loss has been shown to improve glycemic control and decrease …

Chitosan oligosaccharides (COS) display various biological activities. In this study, we
aimed to explore the preventive effects of COS on glucolipid metabolism disorder using …

Objective: This study aimed to determine whether chitosan oligosaccharide (COST)
improves overweight by reducing endoplasmic reticulum (ER) stress in the liver and liver …

Chitooligosaccharide is beneficial for inhibiting dyslipidemia and reducing atherosclerotic
and hyperlipidemic risk. The purpose of this study was to investigate the cholesterol …

The present study examined and compared the effects of low-and high-molecular weight
(MW) chitosan, a nutraceutical, on lipid metabolism in the intestine and liver of high-fat (HF) …

This study investigated the anti-obesity effect of a polysaccharide-rich red algae Gelidium
amansii hot-water extract (GHE) in high-fat (HF) diet-induced obese hamsters. GHE …